We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
89 hedge funds and large institutions have $65.8M invested in Invesco Pharmaceuticals ETF in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
2% more funds holding
Funds holding: 87 → 89 (+2)
3.27% less ownership
Funds ownership: 21.5% → 18.22% (-3.3%)
12% less capital invested
Capital invested by funds: $75.1M → $65.8M (-$9.27M)
28% less call options, than puts
Call options by funds: $2.56M | Put options by funds: $3.57M
Holders
89
Holders Change
+2
Holders Change %
+2.3%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
24
Reduced
21
Closed
10
Calls
$2.56M
Puts
$3.57M
Net Calls
-$1.02M
Net Calls Change
-$1.02M
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.92M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.35M |
| 3 |
Morgan Stanley
New York
|
+$678K |
| 4 |
Citigroup
New York
|
+$409K |
| 5 |
LPL Financial
San Diego,
California
|
+$303K |
